<DOC>
	<DOCNO>NCT02806895</DOCNO>
	<brief_summary>This trial randomize , double-blind , placebo-controlled , crossover study evaluate effect JZP-110 driving performance subject excessive sleepiness due obstructive sleep apnea .</brief_summary>
	<brief_title>Study Assessing Effects JZP-110 Driving Performance Treatment Excessive Sleepiness OSA</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Disorders Excessive Somnolence</mesh_term>
	<criteria>1 . Male female , age 21 65 year inclusive 2 . Diagnosis obstructive sleep apnea ( OSA ) per ICSD3 3 . BMI 18 &lt; 40 kg/m2 4 . Willing able provide write informed consent 1 . Female subject pregnant , nursing , lactate 2 . Any clinically relevant medical , behavioral , psychiatric disorder OSA associate excessive sleepiness 3 . History presence bipolar disorder , bipolar related disorder , schizophrenia , schizophrenia spectrum disorder , psychotic disorder accord DSM5 criterion 4 . History presence unstable medical condition , behavioral psychiatric disorder ( include active suicidal ideation ) , surgical history could affect safety subject interfere study efficacy and/or safety assessment per judgment investigator 5 . History bariatric surgery within past year history gastric bypass procedure 6 . Presence history significant cardiovascular disease 7 . Unable washout refrain take overthecounter ( OTC ) prescription medication could affect sleepwake function</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Driving</keyword>
</DOC>